{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:44:15Z","timestamp":1787856255341,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.rmed.2022.106924","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:35:01Z","timestamp":1655951701000},"page":"106924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study"],"prefix":"10.1016","volume":"200","author":[{"given":"Lei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-6606","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Gerard","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2022.106924_bib1","series-title":"Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2015"},{"key":"10.1016\/j.rmed.2022.106924_bib2","doi-asserted-by":"crossref","first-page":"S522","DOI":"10.1016\/S0091-6749(00)90055-1","article-title":"Asthma: a disease of inflammation and repair","volume":"105","author":"Djukanovi\u0107","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2022.106924_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.rmed.2016.01.012","article-title":"Bronchodilator response as a marker of poor asthma control","volume":"112","author":"Heffler","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2022.106924_bib4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.14-2457","article-title":"Biomarker profiles in asthma with high vs low airway reversibility and poor disease control","volume":"148","author":"Busse","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2022.106924_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaip.2015.05.005","article-title":"Progression of irreversible airflow limitation in asthma: correlation with severe exacerbations","volume":"3","author":"Matsunaga","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2022.106924_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jaci.2007.07.042","article-title":"Airway remodeling and lack of bronchodilator response in steroid-resistant asthma","volume":"125","author":"Goleva","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2022.106924_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1378\/chest.14-2413","article-title":"Improved criterion for assessing lung function reversibility","volume":"148","author":"Ward","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2022.106924_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12931-017-0587-9","article-title":"Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?","volume":"18","author":"Kim","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2022.106924_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2022.106924_bib10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.chest.2016.12.017","article-title":"Bronchodilator response in FVC is larger and more relevant than in FEV(1) in severe airflow obstruction","volume":"151","author":"Quanjer","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2022.106924_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00904-2018","article-title":"Immediate bronchodilator response in FEV(1) as a diagnostic criterion for adult asthma","volume":"53","author":"Tuomisto","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2022.106924_bib12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/thx.39.12.928","article-title":"Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits","volume":"39","author":"Tweeddale","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2022.106924_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00561-2019","article-title":"Bronchodilator reversibility in asthma and COPD: findings from three large population studies","volume":"54","author":"Janson","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2022.106924_bib14","first-page":"274","article-title":"Reduced bronchodilator reversibility correlates with severe asthma and more exacerbations: a prospective 12-month cohort study in a real-world setting [abstract]","volume":"24","author":"Liu","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2022.106924_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.21037\/jtd.2017.04.74","article-title":"Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian severe asthma Network","volume":"9","author":"Wang","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.rmed.2022.106924_bib16","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.jaip.2021.03.042","article-title":"Treatable traits in elderly asthmatics from the Australasian severe asthma Network: a prospective cohort study","volume":"9","author":"Wu","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2022.106924_bib17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/13993003.01098-2015","article-title":"Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma","volume":"47","author":"Wang","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2022.106924_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2022.106924_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"ATS\/ERS task force, standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2022.106924_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaip.2014.09.004","article-title":"The allergic asthma phenotype","volume":"2","author":"Schatz","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2022.106924_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","article-title":"Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation","volume":"113","author":"Miranda","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2022.106924_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2006.08.003","article-title":"Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes","volume":"118","author":"Lemi\u00e8re","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2022.106924_bib23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"SIRIUS Investigators, Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2022.106924_bib24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2022.106924_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1398-9995.2012.02832.x","article-title":"Untangling asthma phenotypes and endotypes","volume":"67","author":"Agache","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2022.106924_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1183\/13993003.01824-2014","article-title":"Asthma phenotypes and IgE responses","volume":"47","author":"Froidure","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2022.106924_bib27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2022.106924_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2022.106924_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.rmed.2022.106924_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-2600(18)30432-6","article-title":"Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013","volume":"7","author":"Wang","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2022.106924_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4168\/aair.2020.12.3.485","article-title":"Hospitalization due to asthma exacerbation: a China asthma research Network (CARN) retrospective study in 29 provinces across mainland China","volume":"12","author":"Lin","year":"2020","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.rmed.2022.106924_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1753465816663978","article-title":"Uncontrolled asthma and its risk factors in adult Chinese asthma patients","volume":"10","author":"Zhong","year":"2016","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2022.106924_bib33","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.jaip.2021.03.015","article-title":"Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 \u2265 80% predicted","volume":"9","author":"Hao","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2022.106924_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Asthma clinical research Network of the national heart lung, and blood Institute, significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2022.106924_bib35","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids establishing therapy (FACET) international study group","volume":"337","author":"Pauwels","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2022.106924_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/thx.2009.126722","article-title":"Effects of steroid therapy on inflammatory cell subtypes in asthma","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2022.106924_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.12968\/pnur.2018.29.10.465","article-title":"Management of asthma: adherence, inhaler technique and self-management","volume":"29","author":"Dhruve","year":"2018","journal-title":"Pract. Nurs."},{"key":"10.1016\/j.rmed.2022.106924_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","article-title":"Severe exacerbations and decline in lung function in asthma","volume":"179","author":"O'Byrne","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2022.106924_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","volume":"180","author":"Reddel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2022.106924_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.rmed.2006.07.005","article-title":"Recent asthma exacerbations: a key predictor of future exacerbations","volume":"101","author":"Miller","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2022.106924_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaip.2021.08.006","article-title":"Omalizumab in asthma with fixed airway obstruction: post hoc analysis of EXTRA","volume":"10","author":"Hanania","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2022.106924_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cea.13714","article-title":"Asthma and fixed airflow obstruction: long-term trajectories suggest distinct endotypes","volume":"51","author":"Smith","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2022.106924_bib43","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease","year":"2022"},{"key":"10.1016\/j.rmed.2022.106924_bib44","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jaip.2019.09.033","article-title":"Bronchodilator dose responsiveness in children and adolescents: clinical features and association with future asthma exacerbations","volume":"8","author":"Grunwell","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2022.106924_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/all.13323","article-title":"Airway pathology in severe asthma is related to airflow obstruction but not symptom control","volume":"73","author":"Ferreira","year":"2018","journal-title":"Allergy"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122001895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122001895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:13:21Z","timestamp":1722590001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611122001895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"alternative-id":["S0954611122001895"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106924","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106924"}}